NOTCH1 activating mutations and deletion of CDKN2A/CDKN2B loci (9p21) are found in over 70% of T-ALL cases and considered as secondary but core events in leukemogenesis [135,136,139]. Here, CDKN2A is linked to acute lymphoblastic leukemia.